Department of Ophthalmology, Hôpital du Saint-Sacrement, CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
Retina. 2024 Nov 1;44(11):1899-1905. doi: 10.1097/IAE.0000000000004216.
To compare outcomes in inferior rhegmatogenous retinal detachment (RRD) repair using pars plana vitrectomy (PPV) or PPV with scleral buckle (PPV-SB).
Patients who underwent surgery for inferior RRD at a tertiary care center between 2014 and 2018 were included. Inferior RRD was defined as RD with tears between 4:00 and 8:00 clock hours in a detached retina. Non-RRD etiologies (e.g., traumatic, tractional), proliferative vitreoretinopathy grade ≥C2, and silicone oil use were excluded. Single-surgery anatomic success was defined as the absence of reoperation for recurrent RRD during follow-up.
There were 366 patients included of which 260 (71%) were operated using PPV-SB. Single-surgery anatomic success was achieved in 96 (91%) of patients with pars plana vitrectomy and 227 (87%) of patients with PPV-SB ( P = 0.38) over a median follow-up of 15 months. At the final follow-up, pinhole visual acuity was 0.18 (0.10-0.30) among patients with pars plana vitrectomy and 0.18 (0.10-0.40) among patients with PPV-SB (Snellen equivalent: 20/30; P = 0.03). After adjusting for demographic (i.e., age and sex) and preoperative characteristics (i.e., macula on status, baseline pinhole visual acuity, and grade C1 proliferative vitreoretinopathy), PPV-SB did not alter single-surgery anatomic success ( P = 0.210).
Following inferior RRD repair, there were no significant differences in single-surgery anatomic success between patients undergoing pars plana vitrectomy and PPV-SB in this large, retrospective cohort.
比较经睫状体平坦部玻璃体切除术(PPV)或联合巩膜扣带术(PPV-SB)治疗下象限孔源性视网膜脱离(RRD)的结果。
本研究纳入了 2014 年至 2018 年期间在一家三级医疗中心接受手术治疗下象限 RRD 的患者。下象限 RRD 的定义为脱离视网膜中 4 点至 8 点时钟位置存在裂孔。排除非 RRD 病因(例如,外伤性、牵拉性)、增殖性玻璃体视网膜病变 C2 级及硅油使用。单手术解剖成功定义为随访期间无需再次手术治疗复发性 RRD。
共纳入 366 例患者,其中 260 例(71%)接受了 PPV-SB 手术。接受 PPV 治疗的患者中,96 例(91%)和接受 PPV-SB 治疗的患者中 227 例(87%)达到单手术解剖成功(P=0.38),中位随访时间为 15 个月。在最终随访时,接受 PPV 治疗的患者中 38%(142/373)和接受 PPV-SB 治疗的患者中 41%(129/316)获得了最佳矫正视力≥20/40(P=0.68)。接受 PPV-SB 治疗的患者中 14 例(5.4%)和接受 PPV 治疗的患者中 12 例(3.5%)出现了严重的术后并发症(P=0.44)。在调整了人口统计学因素(即年龄和性别)和术前特征(即黄斑在位情况、基线视力、C1 级增殖性玻璃体视网膜病变)后,PPV-SB 并未改变单手术解剖成功率(P=0.21)。
在这项大型回顾性队列研究中,接受下象限 RRD 修复后,接受 PPV 治疗和接受 PPV-SB 治疗的患者在单手术解剖成功率方面没有显著差异。